The biggest risk for the RUM phosphate project is the currently slated capex cost estimate. With some scoping study work, a FT Study manager and Jeff Landells on the Board, I can see increased project discipline and capex estimates coming down for first delivery. Hold? I think that is a harsh mark.
- Forums
- ASX - By Stock
- RUM
- best days are ahead of us
best days are ahead of us , page-6
Featured News
Add RUM (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online